{"id":"https://openalex.org/W2017357058","doi":"https://doi.org/10.1111/bjh.12565","title":"Phase I, multicentre, dose\u2010escalation trial of monotherapy with milatuzumab (humanized anti\u2010 CD 74 monoclonal antibody) in relapsed or refractory multiple myeloma","display_name":"Phase I, multicentre, dose\u2010escalation trial of monotherapy with milatuzumab (humanized anti\u2010 CD 74 monoclonal antibody) in relapsed or refractory multiple myeloma","alternate_titles":[],"publication_year":2013,"publication_date":"2013-09-25","ids":{"openalex":"https://openalex.org/W2017357058","doi":"https://doi.org/10.1111/bjh.12565","mag":"2017357058","pmid":"https://pubmed.ncbi.nlm.nih.gov/24112026"},"language":"en","primary_location":{"id":"doi:10.1111/bjh.12565","doi":"https://doi.org/10.1111/bjh.12565","is_oa":false,"landing_page_url":"https://doi.org/10.1111/bjh.12565","pdf_url":null,"source":{"id":"https://openalex.org/S153015021","display_name":"British Journal of Haematology","issn_l":"0007-1048","issn":["0007-1048","1365-2141"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-2","ki-jl-1","medline","norway-1","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"British Journal of Haematology","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W2017357058"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5077897003","display_name":"Jonathan L. Kaufman","orcid":"https://orcid.org/0000-0002-5687-6429","observed_orcids":["https://orcid.org/0000-0002-5687-6429"]},"institutions":[{"id":"https://openalex.org/I150468666","display_name":"Emory University","ror":"https://ror.org/03czfpz43","country_code":"US","type":"education","lineage":["https://openalex.org/I150468666"]},{"id":"https://openalex.org/I4390039307","display_name":"Winship Cancer Institute","ror":"https://ror.org/02gars961","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I132943300","https://openalex.org/I150468666","https://openalex.org/I4390039307"]}],"countries":["US"],"is_corresponding":true,"contributor_roles":[],"raw_author_name":"Jonathan L. Kaufman","raw_affiliation_strings":["Emory University School of Medicine Winship Cancer Institute Atlanta GA USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Emory University School of Medicine Winship Cancer Institute Atlanta GA USA","institution_ids":["https://openalex.org/I150468666","https://openalex.org/I4390039307"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5077846750","display_name":"Rub\u00e9n Niesvizky","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1340179700","display_name":"NewYork\u2013Presbyterian Hospital","ror":"https://ror.org/03gzbrs57","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1340179700"]},{"id":"https://openalex.org/I4405272987","display_name":"Weill Cornell Medical Center","ror":"https://ror.org/052v90092","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I205783295","https://openalex.org/I4387153466","https://openalex.org/I4405272987"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Ruben Niesvizky","raw_affiliation_strings":["Weill Cornell Medical College-New York Presbyterian Hospital, New York, NY, USA,"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Weill Cornell Medical College-New York Presbyterian Hospital, New York, NY, USA,","institution_ids":["https://openalex.org/I1340179700","https://openalex.org/I4405272987"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5029801761","display_name":"Edward Allen Stadtmauer","orcid":"https://orcid.org/0000-0002-3935-6069","observed_orcids":["https://orcid.org/0000-0002-3935-6069"]},"institutions":[{"id":"https://openalex.org/I4390039297","display_name":"Abramson Cancer Center","ror":"https://ror.org/01hvpjq66","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210143392","https://openalex.org/I4390039297"]},{"id":"https://openalex.org/I79576946","display_name":"University of Pennsylvania","ror":"https://ror.org/00b30xv10","country_code":"US","type":"education","lineage":["https://openalex.org/I79576946"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Edward A. Stadtmauer","raw_affiliation_strings":["Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA, USA","institution_ids":["https://openalex.org/I4390039297","https://openalex.org/I79576946"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5010286156","display_name":"Asher Alban Chanan-Khan","orcid":"https://orcid.org/0000-0002-4702-6772","observed_orcids":["https://orcid.org/0000-0002-4702-6772"]},"institutions":[{"id":"https://openalex.org/I1292894508","display_name":"Roswell Park Comprehensive Cancer Center","ror":"https://ror.org/0499dwk57","country_code":"US","type":"facility","lineage":["https://openalex.org/I1292894508"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Asher Chanan\u2010Khan","raw_affiliation_strings":["Roswell Park Cancer Institute Buffalo, NY USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Roswell Park Cancer Institute Buffalo, NY USA","institution_ids":["https://openalex.org/I1292894508"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5023752321","display_name":"David Samuel DiCapua Siegel","orcid":"https://orcid.org/0000-0002-3604-2574","observed_orcids":["https://orcid.org/0000-0002-3604-2574"]},"institutions":[{"id":"https://openalex.org/I1324520350","display_name":"Hackensack University Medical Center","ror":"https://ror.org/008zj0x80","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1324520350"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"David Siegel","raw_affiliation_strings":["Hackensack University Medical Center, Hackensack, NJ, USA;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Hackensack University Medical Center, Hackensack, NJ, USA;","institution_ids":["https://openalex.org/I1324520350"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5031962740","display_name":"Heather Bethea Horne","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210126919","display_name":"Immunomedics (United States)","ror":"https://ror.org/02pf50490","country_code":"US","type":"company","lineage":["https://openalex.org/I4210126919"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Heather Horne","raw_affiliation_strings":["Immunomedics Inc Morris Plains NJ USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Immunomedics Inc Morris Plains NJ USA","institution_ids":["https://openalex.org/I4210126919"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5014083764","display_name":"William A. Wegener","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210126919","display_name":"Immunomedics (United States)","ror":"https://ror.org/02pf50490","country_code":"US","type":"company","lineage":["https://openalex.org/I4210126919"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"William A. Wegener","raw_affiliation_strings":["Immunomedics Inc Morris Plains NJ USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Immunomedics Inc Morris Plains NJ USA","institution_ids":["https://openalex.org/I4210126919"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5003890903","display_name":"David M. Goldenberg","orcid":"https://orcid.org/0000-0001-5539-421X","observed_orcids":["https://orcid.org/0000-0001-5539-421X"]},"institutions":[{"id":"https://openalex.org/I4210126919","display_name":"Immunomedics (United States)","ror":"https://ror.org/02pf50490","country_code":"US","type":"company","lineage":["https://openalex.org/I4210126919"]}],"countries":["US"],"is_corresponding":true,"contributor_roles":[],"raw_author_name":"David M. Goldenberg","raw_affiliation_strings":["Immunomedics Inc Morris Plains NJ USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Immunomedics Inc Morris Plains NJ USA","institution_ids":["https://openalex.org/I4210126919"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":9,"corresponding_author_ids":["https://openalex.org/A5003890903","https://openalex.org/A5077897003"],"corresponding_institution_ids":["https://openalex.org/I150468666","https://openalex.org/I4210126919","https://openalex.org/I4390039307"],"apc_list":{"value":5190,"currency":"USD","value_usd":5190},"apc_paid":null,"fwci":5.643,"has_fulltext":false,"cited_by_count":131,"citation_normalized_percentile":{"value":0.9654029,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":92,"max":99},"biblio":{"volume":"163","issue":"4","first_page":"478","last_page":"486"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10649","display_name":"Multiple Myeloma Research and Treatments","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10649","display_name":"Multiple Myeloma Research and Treatments","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11016","display_name":"Monoclonal and Polyclonal Antibodies Research","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10137","display_name":"Multiple Sclerosis Research Studies","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2728","display_name":"Clinical Neurology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/cd74","display_name":"CD74","score":0.8899999856948853},{"id":"https://openalex.org/keywords/multiple-myeloma","display_name":"multiple myeloma","score":0.9649999737739563},{"id":"https://openalex.org/keywords/relapsed-refractory-multiple-myeloma","display_name":"relapsed/refractory multiple myeloma","score":0.9139999747276306},{"id":"https://openalex.org/keywords/monoclonal-antibody-therapy","display_name":"monoclonal antibody therapy","score":0.8019999861717224},{"id":"https://openalex.org/keywords/dose-escalation","display_name":"dose escalation","score":0.6830000281333923},{"id":"https://openalex.org/keywords/pharmacokinetics","display_name":"pharmacokinetics","score":0.6779999732971191},{"id":"https://openalex.org/keywords/pharmacodynamics","display_name":"pharmacodynamics","score":0.7850000262260437},{"id":"https://openalex.org/keywords/b-cell-depletion","display_name":"B-cell depletion","score":0.7960000038146973},{"id":"https://openalex.org/keywords/drug-conjugates","display_name":"drug conjugates","score":0.49799999594688416},{"id":"https://openalex.org/keywords/anti-drug-antibody","display_name":"anti-drug antibody","score":0.5130000114440918},{"id":"https://openalex.org/keywords/stable-disease","display_name":"stable disease","score":0.6010000109672546}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.8184093832969666},{"id":"https://openalex.org/C142424586","wikidata":"https://www.wikidata.org/wiki/Q7307572","display_name":"Refractory (planetary science)","level":2,"score":0.6255444288253784},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.5394499897956848},{"id":"https://openalex.org/C90924648","wikidata":"https://www.wikidata.org/wiki/Q120569","display_name":"Gastroenterology","level":1,"score":0.5190366506576538},{"id":"https://openalex.org/C2776364478","wikidata":"https://www.wikidata.org/wiki/Q467635","display_name":"Multiple myeloma","level":2,"score":0.48904547095298767},{"id":"https://openalex.org/C111113717","wikidata":"https://www.wikidata.org/wiki/Q725307","display_name":"Pharmacodynamics","level":3,"score":0.48389849066734314},{"id":"https://openalex.org/C29730261","wikidata":"https://www.wikidata.org/wiki/Q274160","display_name":"Toxicity","level":2,"score":0.47672930359840393},{"id":"https://openalex.org/C2777063308","wikidata":"https://www.wikidata.org/wiki/Q1435822","display_name":"Neutropenia","level":3,"score":0.45143985748291016},{"id":"https://openalex.org/C2911091166","wikidata":"https://www.wikidata.org/wiki/Q106419912","display_name":"Transplantation","level":2,"score":0.4319772720336914},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.379194974899292},{"id":"https://openalex.org/C112705442","wikidata":"https://www.wikidata.org/wiki/Q323936","display_name":"Pharmacokinetics","level":2,"score":0.34672534465789795},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.3220309019088745},{"id":"https://openalex.org/C87355193","wikidata":"https://www.wikidata.org/wiki/Q411","display_name":"Astrobiology","level":1,"score":0.0},{"id":"https://openalex.org/C121332964","wikidata":"https://www.wikidata.org/wiki/Q413","display_name":"Physics","level":0,"score":0.0}],"mesh":[{"descriptor_ui":"D000328","descriptor_name":"Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000368","descriptor_name":"Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000369","descriptor_name":"Aged, 80 and over","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000944","descriptor_name":"Antigens, Differentiation, B-Lymphocyte","qualifier_ui":"Q000276","qualifier_name":"immunology","is_major_topic":false},{"descriptor_ui":"D000949","descriptor_name":"Histocompatibility Antigens Class II","qualifier_ui":"Q000276","qualifier_name":"immunology","is_major_topic":false},{"descriptor_ui":"D004305","descriptor_name":"Dose-Response Relationship, Drug","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008875","descriptor_name":"Middle Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D009101","descriptor_name":"Multiple Myeloma","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D009101","descriptor_name":"Multiple Myeloma","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D012008","descriptor_name":"Recurrence","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D061067","descriptor_name":"Antibodies, Monoclonal, Humanized","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":true},{"descriptor_ui":"D061067","descriptor_name":"Antibodies, Monoclonal, Humanized","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D061067","descriptor_name":"Antibodies, Monoclonal, Humanized","qualifier_ui":"Q000493","qualifier_name":"pharmacokinetics","is_major_topic":false}],"locations_count":4,"locations":[{"id":"doi:10.1111/bjh.12565","doi":"https://doi.org/10.1111/bjh.12565","is_oa":false,"landing_page_url":"https://doi.org/10.1111/bjh.12565","pdf_url":null,"source":{"id":"https://openalex.org/S153015021","display_name":"British Journal of Haematology","issn_l":"0007-1048","issn":["0007-1048","1365-2141"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-2","ki-jl-1","medline","norway-1","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"British Journal of Haematology","raw_type":"journal-article"},{"id":"pmid:24112026","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/24112026","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"British journal of haematology","raw_type":"Clinical Trial, Phase I"},{"id":"mag:3046812764","doi":null,"is_oa":false,"landing_page_url":"https://jglobal.jst.go.jp/detail?JGLOBAL_ID=201402286787807197&rel=0","pdf_url":null,"source":{"id":"https://openalex.org/S153015021","display_name":"British Journal of Haematology","issn_l":"0007-1048","issn":["0007-1048","1365-2141"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-2","ki-jl-1","medline","norway-1","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":"British Journal of Haematology","raw_type":null},{"id":"mag:3046891596","doi":null,"is_oa":false,"landing_page_url":"https://jglobal.jst.go.jp/detail?JGLOBAL_ID=201402286787807197","pdf_url":null,"source":{"id":"https://openalex.org/S153015021","display_name":"British Journal of Haematology","issn_l":"0007-1048","issn":["0007-1048","1365-2141"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-2","ki-jl-1","medline","norway-1","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":"British Journal of Haematology","raw_type":null}],"best_oa_location":null,"sustainable_development_goals":[{"score":1.0,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"study_designs":[{"display_name":"Clinical Trial","id":"https://openalex.org/study-designs/clinical-trial"}],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":35,"referenced_works":["https://openalex.org/W1488957585","https://openalex.org/W1978377409","https://openalex.org/W1992443497","https://openalex.org/W1992538067","https://openalex.org/W1996046011","https://openalex.org/W1997890624","https://openalex.org/W2000130439","https://openalex.org/W2006382315","https://openalex.org/W2015451788","https://openalex.org/W2021954218","https://openalex.org/W2022772870","https://openalex.org/W2024520647","https://openalex.org/W2034643379","https://openalex.org/W2040598177","https://openalex.org/W2050704142","https://openalex.org/W2090739823","https://openalex.org/W2096207943","https://openalex.org/W2117887415","https://openalex.org/W2121887447","https://openalex.org/W2124560610","https://openalex.org/W2127760782","https://openalex.org/W2134364025","https://openalex.org/W2138241344","https://openalex.org/W2143369565","https://openalex.org/W2144129115","https://openalex.org/W2148188974","https://openalex.org/W2155366350","https://openalex.org/W2156047731","https://openalex.org/W2158508282","https://openalex.org/W2165948908","https://openalex.org/W2168267840","https://openalex.org/W2169087490","https://openalex.org/W2465279208","https://openalex.org/W2986222831","https://openalex.org/W4238995963"],"related_works":["https://openalex.org/W2247086321","https://openalex.org/W2589461025","https://openalex.org/W2029664590","https://openalex.org/W2526330538","https://openalex.org/W2004362201","https://openalex.org/W4252257778","https://openalex.org/W2559780739","https://openalex.org/W2552091371","https://openalex.org/W4402653629","https://openalex.org/W2015451788"],"abstract_inverted_index":{"CD74,":[0],"expressed":[1],"in":[2,182,215],"multiple":[3],"myeloma":[4],"(MM),":[5],"was":[6,136],"evaluated":[7],"as":[8,221],"a":[9,20,59,222],"target":[10],"for":[11,167,193,200,213],"immunotherapy":[12],"with":[13,27,83,113,141,154,217],"milatuzumab":[14,31,135],"(a":[15],"humanized":[16],"anti-CD74":[17],"antibody).":[18],"In":[19],"multicentre":[21],"dose":[22],"escalation":[23],"study,":[24],"25":[25],"patients":[26,177],"advanced":[28],"MM":[29],"received":[30],"doses":[32],"of":[33,61,130,175,207],"1.5":[34],"(N":[35,39,43,49,75,80],"=":[36,40,44,50,76,81],"8),":[37],"4.0":[38,91],"9),":[41],"8.0":[42],"4)":[45,51],"or":[46,78,220],"16.0":[47],"mg/kg":[48],"administered":[52],"twice":[53],"weekly":[54],"x":[55],"4.":[56],"They":[57],"had":[58,190],"median":[60],"5":[62,174],"prior":[63],"treatments":[64],"(17":[65],"post":[66],"\u2265":[67,194],"1":[68],"stem":[69],"cell":[70],"transplantation)":[71],"and":[72,97,145,169,186,205],"were":[73,101,151,160],"refractory":[74,188],"7)":[77],"relapsed":[79],"18)":[82],"generally":[84,187],"short-lived":[85],"responses":[86,163],"to":[87],"last":[88],"treatment":[89,155,181],"(median":[90,156],"months).":[92,202],"After":[93],"increasing":[94],"prophylactic":[95],"medications":[96],"slowing":[98],"administration,":[99],"infusions":[100],"well":[102],"tolerated":[103],"(National":[104],"Cancer":[105],"Institute-Common":[106],"Terminology":[107],"Criteria":[108],"v3":[109],"toxicity":[110,116],"Grades":[111],"1-2)":[112],"no":[114,161],"dose-limiting":[115],"at":[117],"higher":[118],"doses.":[119],"Only":[120],"one":[121],"patient":[122],"developed":[123],"borderline":[124],"positive":[125],"human":[126],"anti-milatuzumab":[127],"antibody":[128],"titres":[129],"uncertain":[131],"clinical":[132],"significance.":[133],"Although":[134],"rapidly":[137],"cleared":[138],"from":[139],"circulation":[140],"little":[142],"serum":[143],"accumulation":[144],"low":[146],"trough":[147],"levels,":[148],"B-cell":[149],"levels":[150],"moderately":[152],"decreased":[153],"decrease,":[157],"34%).":[158],"There":[159],"objective":[162],"by":[164],"European":[165],"Group":[166],"Blood":[168],"Marrow":[170],"Transplantation":[171],"criteria,":[172],"but":[173],"19":[176],"(26%)":[178],"who":[179],"completed":[180],"this":[183],"heavily":[184],"pretreated":[185],"group":[189],"stable":[191],"disease":[192],"3":[195],"months":[196],"post-treatment":[197],"(one":[198],"continuing":[199],"17":[201],"Disease":[203],"stabilization":[204],"evidence":[206],"pharmacodynamic":[208],"activity":[209],"support":[210],"further":[211],"development":[212],"use":[214],"combination":[216],"other":[218],"agents":[219],"drug":[223],"conjugate.":[224]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W2017357058","counts_by_year":[{"year":2026,"cited_by_count":7},{"year":2025,"cited_by_count":4},{"year":2024,"cited_by_count":14},{"year":2023,"cited_by_count":11},{"year":2022,"cited_by_count":7},{"year":2021,"cited_by_count":14},{"year":2020,"cited_by_count":8},{"year":2019,"cited_by_count":7},{"year":2018,"cited_by_count":11},{"year":2017,"cited_by_count":8},{"year":2016,"cited_by_count":15},{"year":2015,"cited_by_count":13},{"year":2014,"cited_by_count":4},{"year":2013,"cited_by_count":1},{"year":2012,"cited_by_count":1}],"updated_date":"2026-11-20T13:11:24.684918","created_date":"2016-06-24T00:00:00"}
